
The US Food and Drug Administration (FDA) has granted Breakthrough Device Designation (BDD) to EvoLiver, Mursla Bioโs surveillance platform for …

Boehringer Ingelheim has announced results from the phase 2 trial of survodutide for the treatment of liver disease due to …

French clinical stage biopharmaceutical company Inventiva has announced a collaboration with US-based high-technology company Echosens to bring attention to, and …

A new method from Swiss Biotech Versantis promises to give far better immediate care and offer a treatment for a …

Rocheโs subsidiary Genentech has finalised a definitive agreement to acquire Jecure, a US-based biotech which focuses on the discovery of …

A study emerging from the University of California, San Diego, has revealed a correlation between the use of common acid …

Researchers from KTH The Royal Institute of Technology and Gothenburg University have identified new drug targets in the treatment of …

Intercept Pharmaceuticals has announced that Ocaliva (obeticholic acid) has been approved by the National Institute for Health and Care Excellence …
A new treatment from Janssen which could help cure many more patients with hepatitis C has been submitted in Europe. …
Astellas has teamed up with Cytori Therapeutics to develop a range of new stem cell treatments for liver disease and …
A trio of national clinical directors, whose areas of influence cover dementia, older people and liver disease, have been appointed …